We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Events

09 Feb 2026 - 12 Feb 2026
22 Feb 2026 - 24 Feb 2026

Noninvasive Device Monitors Parkinson’s Patients, Informs Treatment Decisions

By HospiMedica International staff writers
Posted on 05 May 2016
An innovative new companion monitoring tool worn like a wristwatch could help provide more effective therapy for patients with Parkinson's disease and other disorders that affect movement by better informing the decisions of physicians who treat them.

A Cedars-Sinai (Los Angeles, CA, USA) research team is one of the first in the nation to test the Personal KinetiGraph (PKG) data logger, which tracks the movements of Parkinson's patients every 2 minutes over a period of 6–10 days. More...
The information enables neurologists to generate reports showing the fluctuations of Parkinson's symptoms throughout the day and the timing of when patients take their medication.

Michele Tagliati, MD, Cedars-Sinai, said the device could be a game-changer for treatment of patients with advanced Parkinson's disease by providing an objective record of movement fluctuations. Such information can enhance doctors' understanding of the nature and progression of the brain disorder. The device also vibrates to remind patients to press a button indicating that they have taken their medication.

"This technology could help us as physicians better inform our patients of treatment options, such as when to have an aggressive therapy like deep brain stimulation," said Dr. Tagliati, "A more refined approach to treating the symptoms of the disease will ultimately lead to a better quality of life for our patients."

Currently, one of the biggest challenges neurologists face when managing Parkinson's patients is making treatment decisions based on relatively brief patient interactions and subjective patient reports about symptoms. "It's virtually impossible to make a well-informed treatment plan based on how patients feel they have been doing in the last three months, because often they don't remember," said Dr. Tagliati, "The PKG device provides a quantitative way to monitor and understand the fluctuations of movements in our patients when they are not in the office."

Dr. Tagliati and colleague Echo Tan, MD, have sought to more fully understand the disease. After the US Food and Drug Administration (FDA) cleared the device in 2014, they launched a 60-patient clinical trial to study its effectiveness. The study includes patients from various stages of Parkinson's disease. Preliminary findings have been valuable. For example, one patient said his medication stopped working after three hours, whereas the report generated by the watch device showed that the drug hadn't worked at all. This information prompted Dr. Tan to change the patient's prescription.

"The watch works great," said a study patient, "It makes it more objective as opposed to subjective. Like the pain scale, for example. They ask you to rate your pain on a scale of 0 to 10, but my 5 might be your 9, or my 5 might be your 1."

Related Links:
Cedars-Sinai
Global Kinetics


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The light-activated Janus patches also hold great potential for various applications beyond neurosurgery (Kang, et al. Chemical Engineering Journal, 2026; DOI: 10.1016/j.cej.2025.171881)

Light-Activated Tissue Adhesive Patch Achieves Rapid and Watertight Neurosurgical Sealing

Durotomy, a tear in the dura mater during neurosurgery, can lead to cerebrospinal fluid leakage, delayed healing, headaches, and serious infections. Achieving a reliable, watertight dural closure is therefore... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: WHX in Dubai brings together over 235,000 professional visits and more than 4,300 global exhibitors from more than 180 countries

WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition

World Health Expo (WHX), formerly Arab Health, will bring together the UAE’s health authorities and leading healthcare sector bodies when the exhibition debuts at the Dubai Exhibition Centre (DEC) from... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.